We welcome requests for further information or interviews.
Robert Robinson Avenue
The Oxford Science Park
Circassia is a world-class specialty pharmaceutical business focused on respiratory disease. Circassia sells its market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom, China, Germany and Italy, and in a wide range of other countries through its network of partners. In the United States, the Company has the commercial rights to chronic obstructive pulmonary disease (COPD) treatments Tudorza® and Duaklir®. Circassia also has the US and Chinese commercial rights to the late-stage ventilator-compatible nitric oxide product LungFit PH*.
*LungFit PH is not an approved name for the product and may not be the final name submitted for approval.
Circassia Group PLC may use your personal information to contact you by email, telephone or post to respond to your query.